TD Cowen Raises Insulet (PODD) Price Target, Maintains Buy Rating
On June 4, TD Cowen has lifted its price target on Insulet Corporation (NASDAQ:PODD) to $379 from $324 while reiterating a Buy rating, pointing to strong early-year performance...
Posts Tagged ‘NASDAQ:PODD’
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Rating
On May 30, Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD)’s stock, assigning a “Buy” rating with the price objective of $380.00, as reported by The...
10 Stocks Analysts Are Upgrading Today
The easing of the US-China trade war is the catalyst driving equity markets higher after weeks of heightened volatility.
Insulet Corporation (NASDAQ:PODD) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter Earnings Call. At this time, all participants are in a listen-only mode.
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Insulet Corporation (NASDAQ:PODD) Q4 2024 Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD) Q4 2024 Earnings Call Transcript February 20, 2025Insulet Corporation beats earnings expectations.
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Call Transcript November 7, 2024Insulet Corporation beats earnings expectations.
Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” third quarter 2024 investor letter.
Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets.
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
Fidelity Investments, an investment management company, released its “Fidelity Growth Strategies Fund” second quarter 2024 investor letter.
Insulet’s (PODD) Sales And Margins Surpassed Expectations
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” second quarter 2024 investor letter.
Insulet Corporation (NASDAQ:PODD) Q2 2024 Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD) Q2 2024 Earnings Call Transcript August 8, 2024Insulet Corporation misses on earnings expectations.
Insulet (PODD) Faces Increasing Competition
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter.
Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter 2024 Earnings Call.
American Politicians are Selling These 10 Stocks
In this article, we will take a detailed look at American Politicians are Selling These 10 Stocks. For a quick overview of such stocks, read our article American Politicians...
5 Best S&P 500 Stocks To Buy According to Analysts
In this piece, we will take a look at the five best S&P 500 stocks to buy according to analysts.
Here’s Why Insulet (PODD) Detracted in Q4
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “ClearBridge Aggressive Growth Strategy” investor letter, which can be downloaded...
Insulet Corporation (NASDAQ:PODD) Q4 2023 Earnings Call Transcript
Insulet Corporation beats earnings expectations. Reported EPS is $1.44, expectations were $0.67.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
14 High Growth NASDAQ Stocks That Are Profitable
In this article, we will take a detailed look at the 14 High Growth NASDAQ Stocks That Are Profitable. For a quick overview of such stocks, read our article 5 High Growth...
17 High Growth Non-Tech Stocks That Are Profitable
In this article, we will take a detailed look at the 17 High Growth Non-Tech Stocks That Are Profitable. For a quick overview of such stocks, read our article 5 High Growth...
Insulet Corporation (PODD) Fell on Negative Sentiment Relating to New Weight Loss Medicine
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, Inc, released the “Carillon Scout Mid Cap Fund” third quarter 2023 investor letter.
Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter.
12 Best Diabetes Stocks To Buy Now
In this article, we shall discuss the 12 best diabetes stocks to buy now.
Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 12 Stock Picks
In this article, we discuss billionaire Daniel Sundheim's D1 Capital portfolio: top 12 stock picks.
10 Best Stocks to Buy on the Dip for Long Term
In this article, we will take a look at the 10 best stocks to buy on the dip for long term.
Insulet Corporation (NASDAQ:PODD) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Third Quarter 2023 Earnings Call.
Here’s Why Insulet Corp. (PODD) Detracted in Q3
The Ithaka Group, an investment advisory firm, released the “Ithaka US Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
14 Best Depressed Stocks To Buy Now
Legendary value investor Howard Marks started writing memos to investors decades ago.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Insulet Corporation (NASDAQ:PODD) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Second Quarter 2023 Earnings Call. [Operator Instructions].
Competitive Pressure Dragged Insulet Corp. (PODD) in Q2
The Ithaka Group, an investment advisory firm, released “Ithaka US Growth Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Insulet Corporation (NASDAQ:PODD) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter 2023 Earnings Call.
Should You Invest in Insulet Corporation (PODD)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2022 investor letter.
Multiple Reasons for the Outperformance of Insulet Corporation (PODD) in Q4
Alger Capital, an investment management company, released its “Alger Mid Cap Focus Fund” fourth quarter investor letter. A copy of the same can be downloaded here.
Should You Hold Insulet Corporation (PODD)?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2022 investor letter.
Insulet Corporation (NASDAQ:PODD) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Fourth Quarter and Full Year 2022 Earnings Call. .
15 Biggest Medical Device Companies in the World
In this article, we will take a look at the 15 biggest medical device companies in the world.
10 Best Diabetes Stocks To Buy Now
The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant investments in the sector to generate awareness...
10 Healthcare Stocks Making Moves After Earnings
In this article, we will take a look at the 10 healthcare stocks making moves after earnings.
10 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital
In this article, we talk about the 10 best healthcare stocks to buy now according to Motley Fool's 1623 Capital.
Billionaire Daniel Sundheim’s D1 Capital Portfolio: Top 10 Stock Picks
In this article, we discuss the top 10 stock picks of billionaire Daniel Sundheim’s D1 Capital Partners.
Analysts Just Trimmed Their Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks that recently received price-target cuts from analysts.
Why These 10 Stocks Are Trending on Tuesday
In this article, we will discuss some of the notable stocks trending today.
ClearBridge Investments on Insulet (PODD): “We Still See Room for Significant Operating Margin Expansion Ahead”
ClearBridge Investments, an investment management firm, published its “Aggressive Growth Strategy” first quarter 2022 investor letter – a copy of which can be downloaded...
10 Companies That Topped Profit Expectations
In this article, we will take a look at the 10 companies that topped profit expectations.
Were Expert Investors Right About Insulet Corporation (PODD)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Hedge Funds Aren’t Crazy About Insulet Corporation (PODD) Anymore
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Top 5 Stock Picks of Shashin Shah’s Think Investments
In this article, we will discuss the top 5 stock picks of Shashin Shah's Think Investments.
